Clinical Trial Update: This Was a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder [Phase 3]

View source ↗

Summary

Phase 3 multinational trial evaluating the efficacy and safety of combining solifenacin succinate with mirabegron versus each drug alone or placebo in adults wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urge Incontinence

Drugs mentioned

• Myrbetriq (mirabegron)
• Vesicare (solifenacin succinate)

Snippet

Sponsor: Astellas Pharma Europe B.V. | Conditions: Urinary Bladder Overactive, Urinary Bladder Diseases\Urologic Diseases | Phase 3 | Status: COMPLETED | Results posted: 2018-06-12